Gainers
- Sharps Technology STSS shares increased by 84.2% to $6.89 during Wednesday's regular session. The company's market cap stands at $7.0 million.
- Cellectar Biosciences CLRB stock increased by 61.52% to $0.45. The market value of their outstanding shares is at $20.6 million.
- Hoth Therapeutics HOTH shares increased by 44.59% to $1.33. The company's market cap stands at $17.5 million.
- ModivCare MODV stock moved upwards by 39.58% to $2.68. The market value of their outstanding shares is at $38.4 million.
- Rallybio RLYB shares rose 35.87% to $0.4. The company's market cap stands at $16.6 million.
- Cyclacel Pharmaceuticals CYCCP shares rose 30.0% to $5.2.
Losers
- Reshape Lifesciences RSLS stock declined by 28.1% to $4.85 during Wednesday's regular session. The company's market cap stands at $3.5 million.
- Neogen NEOG shares decreased by 23.22% to $4.61. The company's market cap stands at $999.4 million.
- NuCana NCNA stock fell 22.75% to $0.05. As per the news, the Q1 earnings report came out 2 days ago.
- Moleculin Biotech MBRX stock fell 21.57% to $0.66. The company's market cap stands at $9.3 million.
- Conduit Pharmaceuticals CDT shares fell 18.27% to $2.64. The market value of their outstanding shares is at $2.1 million.
- Lyra Therapeutics LYRA shares declined by 17.92% to $22.64. The market value of their outstanding shares is at $30.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CDTConduit Pharmaceuticals Inc
$2.64-1.49%
Edge Rankings
Momentum
8.05
Price Trend
Short
Medium
Long
CLRBCellectar Biosciences Inc
$0.4111-11.0%
CYCCPCyclacel Pharmaceuticals Inc
$5.20-8.29%
HOTHHoth Therapeutics Inc
$1.27-17.0%
LYRALyra Therapeutics Inc
$25.7012.6%
MBRXMoleculin Biotech Inc
$0.69012.46%
MODVModivCare Inc
$3.9872.3%
NCNANuCana PLC
$0.0422-8.46%
NEOGNeogen Corp
$4.92-0.91%
RLYBRallybio Corp
$0.3595-4.39%
RSLSReshape Lifesciences Inc
$4.66-3.52%
STSSSharps Technology Inc
$5.85-7.29%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in